Acino Overview

  • Year Founded
  • 1835

Year Founded

  • Status
  • Private

  • Employees
  • 3,123

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 4

  • Investments
  • 17

Acino General Information

Description

Provider of contract manufacturing services based in Zurich, Switzerland. The company offers a range of products in various forms, such as tablets, capsules, injectables, and topical solutions, as well as medical devices and diagnostic products, thereby improving patient care and supporting healthcare professionals in drug development.

Contact Information

Website
www.acino.swiss
Formerly Known As
Schweizerhall
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Thurgauerstrasse 36/38
  • 8050 Zurich
  • Switzerland
+41 044
Primary Industry
BPO/Outsource Services
Other Industries
Drug Delivery
Pharmaceuticals
Vertical(s)
Manufacturing
Corporate Office
  • Thurgauerstrasse 36/38
  • 8050 Zurich
  • Switzerland
+41 044

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Acino Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Acino‘s full profile, request access.

Request a free trial

Acino Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Acino Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Acino‘s full profile, request access.

Request a free trial

Acino Investments & Acquisitions (17)

Acino’s most recent deal was a Buyout/LBO with M8 Pharmaceuticals. The deal was made on 04-Dec-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
M8 Pharmaceuticals 04-Dec-2023 Buyout/LBO Distributors (Healthcare)
Pharmax Pharmaceuticals 20-Mar-2023 Buyout/LBO Pharmaceuticals
Aspen (Six South African Prescription Medicines) 01-Mar-2022 Buyout/LBO Buildings and Property
IlmixGroup (Portfolio of Prescription Pharmaceutical Products) 01-Apr-2021 Buyout/LBO Buildings and Property
Takeda Pharmaceuticals (Primary Care Portfolio) 02-Mar-2020 Buyout/LBO Buildings and Property
You’re viewing 5 of 17 investments and acquisitions. Get the full list »

Acino FAQs

  • When was Acino founded?

    Acino was founded in 1835.

  • Where is Acino headquartered?

    Acino is headquartered in Zurich, Switzerland.

  • What is the size of Acino?

    Acino has 3,123 total employees.

  • What industry is Acino in?

    Acino’s primary industry is BPO/Outsource Services.

  • Is Acino a private or public company?

    Acino is a Private company.

  • What is Acino’s current revenue?

    The current revenue for Acino is .

  • Who are Acino’s investors?

    ADQ has invested in Acino.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process